Aberrant expression of collapsin response mediator proteins-1, -2 and -5 in the brain of intrauterine growth restricted rats

International Journal of Developmental Neuroscience

Volumn 31, Issue 1, 2013, Pages 53-60

  Aravidou, Eftychia ^a,b   Tsangaris, George ^c   Samara, Athina ^a,c   Dontas, Ismene ^a   Botsis, Dimitrios ^b   Aravidis, Christos ^a   Chrousos, George P ^a,c   Malamitsi Puchner, Ariadne ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Brain development; Collapsin response mediator protein; Dihydropyrimidinase related protein; Intrauterine growth restriction; Proteomics; Rat model; Two dimensional electrophoresis; Western blot analysis

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 1; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; COLLAPSIN RESPONSE MEDIATOR PROTEIN 5; DIHYDROPYRIMIDINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN DEVELOPMENT; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FETUS DISTRESS; FUNCTIONAL PROTEOMICS; INTRAUTERINE GROWTH RETARDATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEWBORN; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FETAL GROWTH RETARDATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; PREGNANCY; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

RATTUS;

EID: 84870559286     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2012.10.004     Document Type: Article

References (71)

1. Alexandre-Gouabau M.C., Bailly E., Moyon T.L., Grit I.C., Coupé B., Le Drean G., Rogniaux H.J., Parnet P. Postnatal growth velocity modulates alterations of proteins involved in metabolism and neuronal plasticity in neonatal hypothalamus in rats born with intrauterine growth restriction. Journal of Nutritional Biochemistry 2012, 23:140-152. (PubMed: 21429728).
2. Arimura N., Inagaki N., Chihara K., Ménager C., Nakamura N., Amano M., Iwamatsu A., Goshima Y., Kaibuchi K. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. Journal of Biological Chemistry 2000, 275:23973-23980. (PubMed: 10818093).
3. Arimura N., Menager C., Fukata Y., Kaibuchi K. Role of CRMP-2 in neuronal polarity. Journal of Neurobiology 2004, 58:34-47. (PubMed: 14598368).
4. Arimura N., Menager C., Kawano Y., Yoshimura T., Kawabata S., Hattori A., Fukata Y., Amano M., Goshima Y., Inagaki M., Morone N., Usukura J., Kaibuchi K. Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Molecular and Cellular Biology 2005, 25:9973-9984. (PubMed: 16260611).
5. Barde Y.A. The nerve growth factor family. Progress in Growth Factor Research 1990, 2:237-248. (PubMed: 2133291).
6. Barzilai A., Zilkha-Falb R., Daily D., Stern N., Offen D., Ziv I., Melamed E., Shirvan A. The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity. Journal of Neural Transmission Supplementary 2000, 60:59-76. (PubMed: 11205158).
7. Berndt P., Hobohm U., Langen H. Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 1999, 20:3521-3526. (PubMed: 10612278).
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254. (PubMed: 942051).
9. Bryan S.M., Hindmarsh P. Normal and abnormal fetal growth. Hormone Research 2006, 65:19-27. (PubMed: 16612110).
10. Byk T., Dobransky T., Cifuentes-Diaz C., Sobel A. Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product. Journal of Neuroscience 1996, 16:688-701. (PubMed: 8551352).
11. Byk T., Ozon S., Sobel A. The Ulip family phosphoproteins-common and specific properties. European Journal of Biochemistry 1998, 254:14-24. (PubMed: 9652388).
12. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Markesbery W.R., Butterfield D.A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. Journal of Neurochemistry 2002, 82:1524-1532. (PubMed: 12354300).
13. Charrier E., Reibel S., Rogemond V., Aguera M., Thomasset N., Honnorat J. Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Molecular Neurobiology 2003, 28:51-64. (PubMed: 14514985).
14. Charrier E., Mosinger B., Meissirel C., Aguera M., Rogemond V., Reibel S., Salin P., Chounlamountri N., Perrot V., Belin M.F., Goshima Y., Honnorat J., Thomasset N., Kolattukudy P. Transient alterations in granule cell proliferation, apoptosis and migration in postnatal developing cerebellum of CRMP1-/- mice. Genes to Cells 2006, 11:1337-1352. (PubMed: 17121542).
15. Chen A., Liao W.P., Lu Q., Wong W.S., Wong P.T. Upregulation of dihydropyrimidinase-related protein 2, spectrin alpha II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats-a proteomics approach. Neurochemistry International 2007, 50:1078-1086. (PubMed: 17196711).
16. Comeau M.R., Johnson R., DuBose R.F., Petersen M., Gearing P., VandenBos T., Park L., Farrah T., Buller R.M., Cohen J.I., Strockbine L.D., Rauch C., Spriggs M.K. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphoring receptor, VESPR. Immunity 1998, 8:473-482. (PubMed: 9586637).
17. Cross S.A., Salomao D.R., Parisi J.E., Kryzer T.J., Bradley E.A., Mines J.A., Lam B.L., Lennon V.A. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Annals of Neurology 2003, 54:38-50. (PubMed: 12838519).
18. Desai M., Crowther N.J., Lucas A., Hales C.N. Organ-selective growth in the offspring of mothers protein-restricted. British Journal of Nutrition 1996, 76:591-603. (PubMed: 8942365).
19. Deshane J., Chaves L., Sarikonda K.V., Isbell S., Wilson L., Kirk M., Grubbs C., Barnes S., Meleth S., Kim H. Proteomics analysis of rat brain protein modulations by grape seed extract. Journal of Agricultural and Food Chemistry 2004, 52:7872-7883. (PubMed: 15612770).
20. Ergaz Z., Avgil M., Ornoy A. Intrauterine growth restriction-etiology and consequences: what do we know about the human situation and experimental animal models?. Reproductive Toxicology 2005, 20:301-322. (PubMed: 15982850).
21. Fountoulakis M., Tsangaris G.T., Maris A., Lubec G. The rat brain hippocampus proteome. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2005, 819:115-129. (PubMed: 15797529).
22. Fowden A.L., Giussani D.A., Forhead A.J. Endocrine and metabolic programming during intrauterine development. Early Human Development 2005, 81:723-734. (PubMed: 16085373).
23. Fowden A.L., Ward J.W., Wooding F.P., Forhead A.J., Constancia M. Programming placental nutrient transport capacity. Journal of Physiology 2006, 572:5-15. (PubMed: 16439433).
24. Fukada M., Watakabe I., Yuasa-Kawada J., Kawachi H., Kuroiwa A., Matsuda Y., Noda M. Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family. Journal of Biological Chemistry 2000, 275:37957-37965. (PubMed: 10956643).
25. Fukata Y., Itoh T.J., Kimura T., Menager C., Nishimura T., Shiromizu T., Watanabe H., Inagaki N., Iwamatsu A., Hotani H., Kaibuchi K. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nature Cell Biology 2002, 4:583-591. (PubMed: 12134159).
26. Garofano A., Czernichow P., Breant B. Postnatal somatic growth and insulin contents in moderate or severe intrauterine growth retardation in the rat. Biologia Neonatorum 1998, 73:89-98. (PubMed: 9483301).
27. Garrow J.S., Fletcher K., Halliday D. Body composition in severe infantile malnutrition. Journal of Clinical Investigation 1965, 44:417-425. (PubMed: 14271301).
28. Goshima Y., Nakamura F., Strittmatter P., Strittmatter S.M. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 1995, 376:509-514. (PubMed: 7637782).
29. Gu Y., Ihara Y. Evidence that CRMP2 is involved in the dynamics of microtubules. Journal of Biological Chemistry 2000, 275:17917-17920. (PubMed: 10770920).
30. Hales C.N., Barker D.J. The thrifty phenotype hypothesis. British Medical Bulletin 2001, 60:5-20. (PubMed: 11809615).
31. Hamajima N., Matsuda K., Sakata S., Tamaki N., Sasaki M., Nonaka M. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 1996, 180:157-163. (PubMed: 8973361).
32. Hanson M.A., Gluckman P.D. Developmental origins of health and disease: new insights. Basic & Clinical Pharmacology & Toxicology 2008, 102:90-93. (PubMed: 18226060).
33. Hedgecock E.M., Culotti J.G., Thomson J.N., Perkins L.A. Axonal guidance mutants of Caenorhabditis elegans identified by filling sensory neurons with fluorescein dyes. Developmental Biology 1985, 111:158-170. (PubMed: 3928418).
34. Honnorat J., Antoine J.C. Paraneoplastic neurological syndromes. Orphanet Journal of Rare Diseases 2007, 2:22. (PubMed: 17480225).
35. Hotta A., Inatome R., Yuasa-Kawada J., Qin Q., Yamamura H., Yanagi S. Critical role of collapsin response mediator protein-associated molecule CRAM for filopodia and growth cone development in neurons. Molecular Biology of the Cell 2005, 16:32-39. (PubMed: 15509652).
36. Inagaki N., Chihara K., Arimura N., Menager C., Kawano Y., Matsuo N., Nishimura T., Amano M., Kaibuchi K. CRMP-2 induces axons in cultured hippocampal neurons. Nature Neuroscience 2001, 4:781-782. (PubMed: 11477421).
37. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Molecular Psychiatry 2000, 5:142-149. (PubMed: 10822341).
38. Jones R.H., Ozanne S.E. Fetal programming of glucose-insulin metabolism. Molecular and Cellular Endocrinology 2009, 297:4-9. (PubMed: 18662742).
39. Kaibuchi K., Kuroda S., Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annual Review of Biochemistry 1999, 68:459-486. (PubMed: 10872457).
40. Kobeissy F.H., Ottens A.K., Zhang Z., Liu M.C., Denslow N.D., Dave J.R., Tortella F.C., Hayes R.L., Wang K.K. Novel differential neuroproteomics analysis of traumatic brain injury in rats. Molecular and Cellular Proteomics 2006, 5:1887-1898. (PubMed: 16801361).
41. Kolodkin A.L. Semaphorin-mediated neuronal growth cone guidance. Progress in Brain Research 1998, 117:115-132. (PubMed: 9932405).
42. Langley-Evans S.C., Sculley D.V. The association between birthweight and longevity in the rat is complex and modulated by maternal protein intake during fetal life. FEBS Letters 2006, 580:4150-4153. (PubMed: 16828754).
43. Lubec G., Nonaka M., Krapfenbauer K., Gratzer M., Cairns N., Fountoulakis M. Expression of the dihydropyrimidinase related protein-2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. Journal of Neural Transmission 1999, 57:161-177. (PubMed: 10666674).
44. Luo Y., Raible D., Raper J.A. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 1993, 75:217-227. (PubMed: 8402908).
45. Luo L. Rho GTPases in neuronal morphogenesis. Nature Reviews Neuroscience 2000, 1:173-180. (PubMed: 11257905).
46. Maloney C.A., Rees W.D. Gene-nutrient interactions during fetal development. Reproduction 2005, 130:401-410. (PubMed: 16183858).
47. Matsuda-Matsumoto H., Iwazaki T., Kashem M.A., Harper C., Matsumoto I. Differential protein expression profiles in the hippocampus of human alcoholics. Neurochemistry International 2007, 51:370-376. (PubMed: 17513015).
48. McMillen I.C., Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiological Reviews 2005, 85:571-633. (PubMed: 15788706).
49. Minturn J.E., Fryer H.J., Geschwind D.H., Hockfield S. TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. Journal of Neuroscience 1995, 15:6757-6766. (PubMed: 7472434).
50. Pasterkamp R.J., Kolodkin A.L. Semaphorin junction: making tracks toward neural connectivity. Current Opinion in Neurobiology 2003, 13:79-89. (PubMed: 12593985).
51. Pittock S.J., Kryzer T.J., Lennon V.A. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Annals of Neurology 2004, 56:715-719. (PubMed: 15468074).
52. Quach T.T., Massicotte G., Belin M.F., Honnorat J., Glasper E.R., Devries A.C., Jakeman L.B., Baudry M., Duchemin A.M., Kolattukudy P.E. CRMP3 is required for hippocampal CA1 dendritic organization and plasticity. FASEB Journal 2008, 22:401-409. (PubMed: 17785607).
53. Quinn C.C., Gray G.E., Hockfield S. A family of proteins implicated in axon guidance and outgrowth. Journal of Neurobiology 1999, 41:158-164. (PubMed: 10504203).
54. Samara A., Vougas K., Papadopoulou A., Anastasiadou E., Baloyanni N., Paronis E., Chrousos G.P., Tsangaris G.T. Proteomics reveal rat hippocampal lateral asymmetry. Hippocampus 2011, 21:108-119. (PubMed: 20020437).
55. Schröder H.J. Models of fetal growth restriction. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003, 110:S29-S39. (PubMed: 12965088).
56. Soothill P.W., Ajayi R.A., Nicolaides K.N. Fetal biochemistry in growth retardation. Early Human Development 1992, 29:91-97. (PubMed: 1396283).
57. Su K.Y., Chien W.L., Fu W.M., Yu I.S., Huang H.P., Huang P.H., Lin S.R., Shih J.Y., Lin Y.L., Hsueh Y.P., Yang P.C., Lin S.W. Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory. Journal of Neuroscience 2007, 27:2513-2524. (PubMed: 17344389).
58. Szitanyi P., Janda J., Poledne R. Intrauterine under nutrition and programming as a new risk of cardiovascular disease in later life. Physiological Research 2003, 52:389-395. (PubMed: 12899650).
59. Takahashi T., Fournier A., Nakamura F., Wang L.H., Murakami Y., Kalb R.G., Fujisawa H., Strittmatter S.M. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999, 99:59-69. (PubMed: 10520994).
60. Tamagnone L., Artigiani S., Chen H., He Z., Ming G.I., Song H., Chedotal A., Winberg M.L., Goodman C.S., Poo M., Tessier-Lavigne M., Comoglio P.M. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999, 99:71-80. (PubMed: 10520995).
61. Tessier-Lavigne M., Goodman C.S. The molecular biology of axon guidance. Science 1996, 274:1123-1133. (PubMed: 8895455).
62. Vaiman D., Gascoin-Lachambre G., Boubred F., Mondon F., Feuerstein J.M., Ligi I., Grandvuillemin I., Barbaux S., Ghigo E., Achard V., Simeoni U., Buffat C. The intensity of IUGR-induced transcriptome deregulations is inversely correlated with the onset of organ function in a rat model. PLoS ONE 2011, 6:e21222. (PubMed: 21731679).
63. Wang L.H., Strittmatter S.M. A family of rat CRMP genes is differentially expressed in the nervous system. Journal of Neuroscience 1996, 16:6197-6207. (PubMed: 8815901).
64. Warner M.J., Ozanne S.E. Mechanisms involved in the developmental programming of adulthood disease. Biochemical Journal 2010, 427:333-347. (PubMed: 20388123).
65. Weitzdoerfer R., Fountoulakis M., Lubec G. Aberrant expression of dihydropyrimidinase related protein-2, -3, and -4 in fetal Down syndrome brain. Journal of Neural Transmission Supplementary 2001, 61:95-107. (PubMed: 11771764).
66. Winberg M.L., Noordermeer J.N., Tamagnone L., Comoglio P.M., Spriggs M.K., Tessier-Lavigne M., Plexin Goodman C.S. A is a neuronal semaphorin receptor that controls axon guidance. Cell 1998, 95:903-916. (PubMed: 9875845).
67. Yamashita N., Uchida Y., Ohshima T., Hirai S., Nakamura F., Taniguchi M., Mikoshiba K., Honnorat J., Kolattukudy P., Thomasset N., Takei K., Takahashi T., Goshima Y. Collapsin response mediator protein 1 mediates reel in signaling in cortical neuronal migration. Journal of Neuroscience 2006, 26:13357-13362. (PubMed: 17182786).
68. Yamashita N., Morita A., Uchida Y., Nakamura F., Usui H., Ohshima T., Taniguchi M., Honnorat J., Thomasset N., Takei K., Takahashi T., Kolattukudy P., Goshima Y. Regulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1. Journal of Neuroscience 2007, 27:12546-12554. (PubMed: 18003833).
69. Yamashita N., Mosinger B., Roy A., Miyazaki M., Ugajin K., Nakamura F., Sasaki Y., Yamaguchi K., Kolattukudy P., Goshima Y. CRMP5 (collapsin response mediator protein 5) regulates dendritic development and synaptic plasticity in the cerebellar Purkinje cells. Journal of Neuroscience 2011, 31:1773-1779. (PubMed: 21289187).
70. Yu Z., Kryzer T.J., Griesmann G.E., Kim K., Benarroch E.E., Lennon V.A. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma related autoimmunity. Annals of Neurology 2001, 49:146-154. (PubMed: 11220734).
71. Yuasa-Kawada J., Suzuki R., Kano F., Ohkawara T., Murata M., Noda M. Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization. European Journal of Neuroscience 2003, 17:2329-2343. (PubMed: 12814366).